Boothbay Fund Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Boothbay Fund Management, LLC
- $5.7 Billion
- Q3 2025
A detailed history of Boothbay Fund Management, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 163,000 shares of ARCT stock, worth $1.19 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
163,000
Previous 50,471
222.96%
Holding current value
$1.19 Million
Previous $656,000
357.93%
% of portfolio
0.05%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ARCT
# of Institutions
168Shares Held
26.5MCall Options Held
2.21MPut Options Held
846K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$15.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.03MShares$14.7 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...